The Abu Dhabi Investment Authority and Singapore’s GIC have bought a minority stake in PPD, valuing the CRO giant at more than $9 billion.

NCGS is expanding its business by relocating to a new corporate headquarters, bringing $10 million in investment and creating 80 new jobs.

Amid new approvals last year, drugmakers also suffered R&D setbacks, cut research staff, rejigged their operations and refocused their pipelines.

Takeda is nearing the final stages of a joint venture with PRA Health Sciences, the product of an expansion of their clinical development partnership in Japan…

A bipartisan bill that plans to allow a tax credit for expenses of contracted research—often done by CROs—has been introduced in the House of Representatives.

WuXi AppTec is seeking an IPO on China’s common stock market, a move that confirmed buzz that the CRO giant would re-enlist its businesses in three pieces.

Parexel has acquired contract medical affairs services provider The Medical Affairs Company as it looks to bolster its outsourced healthcare specialist…

PPD is opening a 24-bed clinical research unit in Las Vegas in support of its early drug development services.

WuXi AppTec, one of the largest CROs in China, has just acquired a Shanghai-based preclinical counterpart, HD Biosciences, building further on its core…

Evotec is participating in the €8 million ($8.46 million) Series A of its current partner in developing metabolic disease therapy Eternygen.